Brief: Maxcyte Buys Sequre Dx For $4.5 Million
Jan 30 (Reuters) - MaxCyte Inc MXCT.O :
* MAXCYTE, INC. MAXCYTE, INC. - MXCR - MAXCYTE® ACQUIRES
SEQURE
DX
* MAXCYTE INC - PAYS $4.5 MILLION FOR SEQURE DX
* MAXCYTE INC - ADDITIONAL $2.5 MILLION CONTINGENT ON
REVENUE
TARGETS
Source text: ID:nRSd1990Va
Further company coverage: MXCT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MaxCyte
See all newsCell-engineering firm MaxCyte's Q3 revenue beats; annual outlook lifted
Brief: MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
MaxCyte Inc reports results for the quarter ended June 30 - Earnings Summary
MaxCyte Q2 revenue beats estimates
MaxCyte Inc expected to post a loss of 9 cents a share - Earnings Preview